This is so awesome! I’m extremely proud to tell you that we will have Rodger Novak closing Labiotech Refresh on May 24th in Berlin.

crispr_labiotech_refresh_novak_speaker_berlin_may

CRISPR is a real revolution in Biotech and gene editing. It’s even considered by many as the discovery of the century and should soon get the Nobel prize. This extremely powerful technology is also moving toward translation into therapeutics.

The leading European company in the field is…CRISPR Therapeutics, co-founded by Novak himself, Emmanuelle Charpentier (one of the co-discoverer of the technology) and Shaun Foy.

Roger_novak_breakthrough_crispr_labiotech_refresh_berlin_emanuelle_charpentier

Rodger Novak, CEO of CRISPR Therapeutics, Breakthrough Prize laureates Jennifer Doudna and Emmanuelle Charpentier with Innovative Genomics Initiative Scientific Director Jacob Corn. (Credit: Rodger Novak / IGI)

It raised €80M in series A and B rounds, signed a monster €2.3Bn deal with Vertex and is on its way to being one of the leading gene therapy company worldwide.

I’m really excited to interview him on stage in one of our 5 fireside chats!

The only thing you need to do is to get your ticket before Friday.

labiotech_refresh_logo_crispr_therapeutics_berlin_may_biotech


Feature Image Credit: Remix of Graphics by Labiotech & Rodger Novak (Source: Rodger Novak)
Previous post

Meet the CEO who wants to transform Pretty Corals into therapies for Cancer

Next post

European Biotech teams up with US Navy to engineer Military Materials

Let's Continue The Conversation

Feel free to send us comments about this article to comments@labiotech.eu and/or comment on that article on social media.